|
1
|
Thomson JA, Itskovitz-Eldor J, Shapiro SS,
et al: Embryonic stem cell lines derived from human blastocysts.
Science. 282:1145–1147. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wagner AM, Krenger W, Holzgreve W, Burkle
P and Surbek DV: Use of human embryonic stem cells and umbilical
cord blood stem cells for research and therapy: a prospective
survey among health care professionals and patients in Switzerland.
Transfusion. 53:2681–2689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Faulkner SD, Vawda R and Fehlings MG:
Adult-derived pluripotent stem cells. World Neurosurg. 82:500–508.
2014. View Article : Google Scholar
|
|
4
|
Cao F, Lin S, Xie X, et al: In vivo
visualization of embryonic stem cell survival, proliferation, and
migration after cardiac delivery. Circulation. 113:1005–1014. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Serakinci N, Christensen R, Fahrioglu U,
et al: Mesenchymal stem cells as therapeutic delivery vehicles
targeting tumor stroma. Cancer Biother Radiopharm. 26:767–773.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakamizo A, Marini F, Amano T, et al:
Human bone marrow-derived mesenchymal stem cells in the treatment
of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
|
7
|
Khakoo AY, Pati S, Anderson SA, et al:
Human mesenchymal stem cells exert potent antitumorigenic effects
in a model of Kaposi’s sarcoma. J Exp Med. 203:1235–1247. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiao L, Xu Z, Zhao T, et al: Suppression
of tumorigenesis by human mesenchymal stem cells in a hepatoma
model. Cell Res. 18:500–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katsuno T, Ochi M, Tominaga K, et al:
Mesenchymal stem cells administered in the early phase of
tumorigenesis inhibit colorectal tumor development in rats. J Clin
Biochem Nutr. 53:170–175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Studeny M, Marini FC, Champlin RE,
Zompetta C, Fidler IJ and Andreeff M: Bone marrow-derived
mesenchymal stem cells as vehicles for interferon-beta delivery
into tumors. Cancer Res. 62:3603–3608. 2002.PubMed/NCBI
|
|
11
|
Zhu W, Xu W, Jiang R, et al: Mesenchymal
stem cells derived from bone marrow favor tumor cell growth in
vivo. Exp Mol Pathol. 80:267–274. 2006. View Article : Google Scholar
|
|
12
|
Djouad F, Plence P, Bony C, et al:
Immunosuppressive effect of mesenchymal stem cells favors tumor
growth in allogeneic animals. Blood. 102:3837–3844. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Studeny M, Marini FC, Dembinski JL, et al:
Mesenchymal stem cells: potential precursors for tumor stroma and
targeted-delivery vehicles for anticancer agents. J Natl Cancer
Inst. 96:1593–1603. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davidoff AM, Ng CY, Brown P, et al: Bone
marrow-derived cells contribute to tumor neovasculature and, when
modified to express an angiogenesis inhibitor, can restrict tumor
growth in mice. Clin Cancer Res. 7:2870–2879. 2001.PubMed/NCBI
|
|
15
|
Patel SA, Heinrich AC, Reddy BY, Srinivas
B, Heidaran N and Rameshwar P: Breast cancer biology: the
multifaceted roles of mesenchymal stem cells. J Oncol.
2008:4258952008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dwyer RM, Khan S, Barry FP, O’Brien T and
Kerin MJ: Advances in mesenchymal stem cell-mediated gene therapy
for cancer. Stem Cell Res Ther. 1:252010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schäffler A and Büchler C: Concise review:
adipose tissue-derived stromal cells - basic and clinical
implications for novel cell-based therapies. Stem Cells.
25:818–827. 2007. View Article : Google Scholar
|
|
18
|
Zhao W, Ren G, Zhang L, et al: Efficacy of
mesenchymal stem cells derived from human adipose tissue in
inhibition of hepatocellular carcinoma cells in vitro. Cancer
Biother Radiopharm. 27:606–613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barry FP and Murphy JM: Mesenchymal stem
cells: clinical applications and biological characterization. Int J
Biochem Cell Biol. 36:568–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zuk PA, Zhu M, Ashjian P, et al: Human
adipose tissue is a source of multipotent stem cells. Mol Biol
Cell. 13:4279–4295. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Preston SL, Alison MR, Forbes SJ, Direkze
NC, Poulsom R and Wright NA: The new stem cell biology: something
for everyone. Mol Pathol. 56:86–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lyden D, Hattori K, Dias S, et al:
Impaired recruitment of bone-marrow-derived endothelial and
hematopoietic precursor cells blocks tumor angiogenesis and growth.
Nat Med. 7:1194–1201. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramasamy R, Lam EW, Soeiro I, Tisato V,
Bonnet D and Dazzi F: Mesenchymal stem cells inhibit proliferation
and apoptosis of tumor cells: impact on in vivo tumor growth.
Leukemia. 21:304–310. 2007. View Article : Google Scholar
|
|
24
|
Sato T, Sakai T, Noguchi Y, Takita M,
Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion
of human uterine cervical carcinoma cells by augmenting the
expression and activation of stromal matrix metalloproteinases.
Gynecol Oncol. 92:47–56. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohlsson LB, Varas L, Kjellman C, Edvardsen
K and Lindvall M: Mesenchymal progenitor cell-mediated inhibition
of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol
Pathol. 75:248–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakamura K, Ito Y, Kawano Y, et al:
Antitumor effect of genetically engineered mesenchymal stem cells
in a rat glioma model. Gene Ther. 11:1155–1164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu GD, Nolta JA, Jin YS, et al: Migration
of mesenchymal stem cells to heart allografts during chronic
rejection. Transplantation. 75:679–685. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barbash IM, Chouraqui P, Baron J, et al:
Systemic delivery of bone marrow-derived mesenchymal stem cells to
the infarcted myocardium: feasibility, cell migration, and body
distribution. Circulation. 108:863–868. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serakinci N, Fahrioglu U and Christensen
R: Mesenchymal stem cells, cancer challenges and new directions.
Eur J Cancer. 50:1522–1530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghannam S, Bouffi C, Djouad F, Jorgensen C
and Noel D: Immunosuppression by mesenchymal stem cells: mechanisms
and clinical applications. Stem Cell Res Ther. 1:22010. View Article : Google Scholar : PubMed/NCBI
|
